[Expedient therapy of chronic pyelonephritis].
D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002701:Chloramphenicol / Q000627:therapeutic use; D002908:Chronic Disease; D003091:Colistin / Q000627:therapeutic use; D003864:Depression, Chemical; D004357:Drug Synergism; D004917:Erythromycin / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D007710:Klebsiella Infections / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009582:Nitrofurantoin / Q000008:administration & dosage / Q000627:therapeutic use*; D009827:Oleandomycin / Q000627:therapeutic use; D010068:Oxacillin / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D011512:Proteus Infections / Q000188:drug therapy*; D011704:Pyelonephritis / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013268:Stimulation, Chemical; D013290:Streptococcal Infections / Q000188:drug therapy*; D013307:Streptomycin / Q000627:therapeutic use; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D010406:Penicillins; D011113:Polymyxins; D013449:Sulfonamides; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D000667:Ampicillin; D009582:Nitrofurantoin; D013752:Tetracycline; D009827:Oleandomycin; D010068:Oxacillin; D013307:Streptomycin; D003091:Colistin
Zur zweckmässigen Therapie der chronischen Pyelonephritis.